Trials / Not Yet Recruiting
Not Yet RecruitingNCT05967481
Evaluation of Study Experiences of Neuroendocrine Tumor Patients
Investigating the Clinical Trial Journey and Engagement of Neuroendocrine Tumor Patients
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Power Life Sciences Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This research will admit a wide range of data on the clinical study experience of neuroendocrine tumor patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with neuroendocrine tumor.
Conditions
Timeline
- Start date
- 2024-08-01
- Primary completion
- 2025-08-01
- Completion
- 2026-08-01
- First posted
- 2023-08-01
- Last updated
- 2023-08-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05967481. Inclusion in this directory is not an endorsement.